European Journal of Gynaecological Oncology

Print ISSN: 0392-2936 | Online ISSN: 2709-0086

European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.


Open Access

Age at first full-term pregnancy and mammographic breast density in postmenopausal women: a systematic review

Magda J. Vandeloo,Eliane Kellen,Carolyn Y. Fang,Kristof Y. Neven,Tim S. Nawrot,Chantal Van Ongeval

DOI: 10.22514/ejgo.2023.016

Abstract ( 451 ) PDF (1.11 MB) ( 176 )

Open Access

Does gas insufflation during oncologic laparoscopic surgery cause dissemination of malignant cells?

Yossi Tzur,Ido Laskov,Asaf Aizic,Ziva Aharon,Avi Beri,Limor Gortzak-Uzan,Dan Grisaru,Nadav Michaan

DOI: 10.22514/ejgo.2023.017

Abstract ( 389 ) PDF (435.96 kB) ( 137 )

Open Access

Risk factors of lymph node metastasis in patients with type II endometrial carcinoma: a retrospective signle-center study

Nan Wang,Zhi-feng Yan,Ming-xia Ye,Ming-xia Li,Ming-yang Wang,Yuan-guang Meng

DOI: 10.22514/ejgo.2023.018

Abstract ( 363 ) PDF (1,013.52 kB) ( 126 )

Open Access

Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study

Jessica Kunzman,Ryan Hutten,Kristen Kelley,Kate Harris,David K. Gaffney,Cristina DeCesaris,Gita Suneja,Lindsay M. Burt

DOI: 10.22514/ejgo.2023.019

Abstract ( 459 ) PDF (3.53 MB) ( 173 )

Open Access

HTR7 and its N6-methyladenosine modification: a potential target in cell cycle regulation of cervical cancer

Guo Chen,Yuting Zhu,Lu Tian,Jie Ying,Shuangyue Wu,Bin Zhang,Yang Song

DOI: 10.22514/ejgo.2023.020

Abstract ( 348 ) PDF (12.19 MB) ( 143 )

Open Access

Comparison of survival outcomes following radiotherapy versus radical hysterectomy in patients with stage IIA cervical squamous cell carcinoma

Mingwei Li,Ping Liu,Danbo Wang,Hui Duan,Xuemei Zhan,Yi Zhang,Qinghuang Xie,Biliang Chen,Zhumei Cui,Qiubo Lv,Hailin Wang,Xiaonong Bin,Jinghe Lang,Chunlin Chen

DOI: 10.22514/ejgo.2023.021

Abstract ( 352 ) PDF (2.93 MB) ( 157 )

Open Access

Identification of ferroptosis-related risk signature and correlation with the overall survival of ovarian cancer

Yibin Liu,Xin Xu,Jianlei Wu,Zhongkang Li,Ye Zhang,Xiaoxiao Zhang,Shike Shui,Hui Li,Tiantian Wang,Juan Zhai,Ruixia Guo,Yanpeng Tian

DOI: 10.22514/ejgo.2023.023

Abstract ( 363 ) PDF (5.54 MB) ( 112 )

Open Access

S100A7 promotes endometrial carcinoma progression by activating the MAPK signaling pathway

Xiaojing Sun,Xin Zhang,Lanhui Yuan,Xinyue Zhang,Yuqin Fu

DOI: 10.22514/ejgo.2023.028

Abstract ( 341 ) PDF (4.62 MB) ( 138 )

Open Access

Radiation associated angiosarcoma of the breast: a pictorial review of eleven cases highlighting a devastating complication of breast radiotherapy

Emma Stewart-Parker,Katharine Kirkpatrick,Lorraine D’Souza,Duraisamy Ravichandran

DOI: 10.22514/ejgo.2023.029

Abstract ( 358 ) PDF (4.37 MB) ( 169 )

Open Access

Immunohistological study of ovarian mature cystic teratoma with extremely elevated SCC antigen level

Kyousuke Takeuchi,Akari Shirakuni,Ai Yoshida,Makoto Sugimoto,Sohei Kitazawa,Hiroki Morita

DOI: 10.22514/ejgo.2023.030

Abstract ( 312 ) PDF (2.1 MB) ( 156 )

Published Ahead of Print

Special Issues

Special issue title:

Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"

Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors

Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD

Submission deadline: 31 December 2022

Special issue title:

Breast Cancer

Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment

Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD

Submission deadline: 30 April 2022

Special issue title:

Systematic Review or Meta-Analysis in Gynaecological Oncology

Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer

Editor: Enrique Hernandez, MD

Submission deadline: 25 April 2022

Special issue title:

Gynecological Cancer Prevention: A New Prospective

Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology

Editor: Ottavia Dʼoria, MD

Submission deadline: 31 October 2023

Special issue title:

Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods

Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer

Editor: Prof. Takuma Hayashi

Submission deadline: 31 October 2023

Special issue title:

Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers

Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms

Editor: Liaqat Ali, PhD

Submission deadline: 31 October 2022

Special issue title:

Polycystic Ovary Syndrome and the Risk of Endometrial Cancer

Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation

Editor: Masuma Khatun, PhD

Submission deadline: 24 June 2023

Special issue title:

The Management of Endometrial Cancer

Keywords: Endometrial Cancer; High-risk Factors; Adjuvant Treatment; Endocrine Therapy; Targeted Therapy

Editor: Nicolae Gica, MD, PhD,Yoland Antill, BMed FRACP MD

Submission deadline: 31 July 2023

Special issue title:

Molecular Characterization in Endometrial Cancer: Progress and Prospects

Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine

Editor: Andrea Giannini, MD, PhD

Submission deadline: 31 December 2022

Special issue title:

Immunotherapy for Gynecological Oncology

Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer

Editor: Tadahiro Shoji, MD

Submission deadline: 31 July 2021

Featured Article

Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181

To Be a Reviewer

If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.

Review for EJGO

Join Editorial Board

You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.

Join Editorial Board


Prof. Enrique Hernandez, MD, FACOG, FACS.

Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.